Radiopharm Theranostics Ltd.

11/14/2026 | Press release | Distributed by Public on 11/14/2026 12:57

Phase 2b Imaging Study of 18F-RAD101 PET for Detection of Recurrent Brain Metastases Following Radiotherapy

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.
Radiopharm Theranostics Ltd. published this content on November 14, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 14, 2026 at 18:57 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]